Target intelligence / Profile preview

Melanoma antigen family B, 16 pseudogene (Null)

Target
Null
Molecular classification
Pseudogene, Processed pseudogene (retrotransposed origin), Other
01

Overview

“Melanoma antigen family B, 16 pseudogene” (ENSG00000233663) is a processed pseudogene originating from a retrotranscribed mRNA of a melanoma antigen family member. By definition, a pseudogene resembles a functional gene but cannot produce a functional protein, usually due to mutations such as premature stop codons, frameshifts, or loss of regulatory elements[2][3][5][6]. Although some pseudogenes have emerging roles as regulators of gene expression (through non-coding RNA mechanisms), there is no evidence that this particular pseudogene is functionally relevant, a biomarker, or a drug target in melanoma or other diseases[1][4][5]. The term “melanoma antigen pseudogene” refers specifically to its sequence similarity to the functional antigen family, but not to any antigenic, protein, or therapeutic function.

Other names
Melanoma antigen family B, 16 pseudogeneLOC100420325Melanoma antigen pseudogeneENSG00000233663
02

Mechanism of action

Null

03

Biological functions

Does not produce functional proteinsPotential regulatory non-coding RNA roles (speculative, not confirmed for this specific pseudogene)
04

Disease associations

No direct role in disease pathology; functional melanoma antigens are important in cancer, but the pseudogene variant does not appear directly implicated.

Beyond the preview

Go deeper on Melanoma antigen family B, 16 pseudogene (Null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melanoma antigen family B, 16 pseudogene (Null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call